An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
This is a personal story about one person’s experience switching between two prescription weight-loss drugs. They started taking Ozempic in January 2025 and lost a lot of weight, going from 167 to 137 pounds by December. Their weight then plateaued, they stopped Ozempic in March 2026 and gained back to 149 pounds. In June 2026 they started Wegovy, slowly increased the dose to 2.4 mg, and after five months their weight has been pretty stable around 144–147 pounds — only a few pounds difference so far. Both Ozempic and Wegovy are brand names for very similar medicines. They’re versions of a drug that acts like a natural gut hormone that tells your body you’re full and slows how fast your stomach empties. In simple terms: these drugs make you feel less hungry and help you eat less. Ozempic was developed for diabetes but is often used off-label for weight loss; Wegovy is the same class of drug but approved specifically for chronic weight management and usually comes in a higher maintenance dose. This report is a single-person anecdote, not a controlled study. It tells us what happened to one person over time, which can be interesting but can’t prove cause-and-effect for everyone. Clinical trials show many people lose substantial weight on these drugs, but individuals vary a lot: some hit plateaus, some regain weight when they stop, and some see smaller changes even after switching formulations or doses. The numbers here — a big drop on Ozempic, regain after stopping, then only modest change on Wegovy over five months — are all within the range of what’s been seen anecdotally and in trials, but we can’t generalize from one story. Why this matters is practical: many people considering these medicines want to know whether switching products or changing doses will break a plateau or give extra weight loss. This anecdote suggests switching isn’t guaranteed to restart big losses, at least not immediately. It also illustrates that stopping a drug often leads to some regain, and that reaching a steady dose doesn’t always mean continued weight loss — sometimes the body adapts and weight stabilizes. Caveats and risks: this is one person’s report, so it may not apply to others. These drugs can cause side effects like nausea, diarrhea, constipation, stomach pain, and in rare cases more serious problems. They require medical supervision and are prescription-only. Stopping them can lead to weight regain. People with certain medical histories (like a personal or family history of a specific type of thyroid tumor) should avoid them; pregnant people shouldn’t use them. If someone is thinking about starting, stopping, or switching medications, they should talk to their doctor to weigh benefits, risks, and alternatives. Bottom line: one person lost a lot on Ozempic, regained after stopping, and saw only small change after five months on Wegovy — an example of how individual responses to these drugs can vary and why medical guidance is important.
Source: r/Semaglutide